Metformin-induced regulation of the intestinal D-glucose transporters.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Physiology and Pharmacology

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 20610860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Positive Regulatory Control Loop between Gut Leptin and Intestinal GLUT2/GLUT5 Transporters Links to Hepatic Metabolic Functions in Rodents

  2009cited by this paper
• Diabetes mellitus and expression of the enterocyte renin-angiotensin system: implications for control of glucose transport across the brush border membrane.

  2009cited by this paper
• Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats.

  2009cited by this paper
• Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.

  2009cited by this paper
• Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein.

  2009cited by this paper
• GLUT2 mutations, translocation, and receptor function in diet sugar managing.

  2009cited by this paper
• Resistin-Like Molecule-β Inhibits SGLT-1 Activity and Enhances GLUT2-Dependent Jejunal Glucose Transport

  2009cited by this paper
• Ambivalent role of gallated catechins in glucose tolerance in humans: a novel insight into non-absorbable gallated catechin-derived inhibitors of glucose absorption.

  2009cited by this paper
• Insulin Internalizes GLUT2 in the Enterocytes of Healthy but Not Insulin-Resistant Mice

  2008cited by this paper
• Metformin and the intestine

  2008cited by this paper
• Sugar absorption in the intestine: the role of GLUT2.

  2008cited by this paper
• Short term 13-cis-retinoic acid treatment at therapeutic doses elevates expression of leptin, GLUT4, PPARgamma and aP2 in rat adipose tissue.

  2008cited by this paper
• Luminal fructose inhibits rat intestinal sodium-phosphate cotransporter gene expression and phosphate uptake.

  2008cited by this paper
• Metformin: a review.

  2008cited by this paper
• AMPK: a key regulator of energy balance in the single cell and the whole organism

  2008cited by this paper
• Metformin Transport by a Newly Cloned Proton-Stimulated Organic Cation Transporter (Plasma Membrane Monoamine Transporter) Expressed in Human Intestine

  2007cited by this paper
• Luminal leptin inhibits intestinal sugar absorption in vivo

  2007cited by this paper
• Involvement of an enterocyte renin–angiotensin system in the local control of SGLT1‐dependent glucose uptake across the rat small intestinal brush border membrane

  2007cited by this paper
• Water transport by GLUT2 expressed in Xenopus laevis oocytes

  2007cited by this paper
• Orexins Control Intestinal Glucose Transport by Distinct Neuronal, Endocrine, and Direct Epithelial Pathways

  2007cited by this paper
• Erratum to “Glucose utilization is suppressed in the gut of insulin-resistant high fat-fed rats and is restored by metformin” [Biochem. Pharmacol. 72 (2) (2006) 198–203]

  2006cited by this paper
• Glucose utilization is suppressed in the gut of insulin-resistant high fat-fed rats and is restored by metformin.

  2006cited by this paper
• Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.

  2006cited by this paper
• Water transport by Na+‐coupled cotransporters of glucose (SGLT1) and of iodide (NIS). The dependence of substrate size studied at high resolution

  2006cited by this paper
• 5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK.

  2005cited by this paper
• Luminal leptin induces rapid inhibition of active intestinal absorption of glucose mediated by sodium-glucose cotransporter 1.

  2005cited by this paper
• Apical GLUT2: a major pathway of intestinal sugar absorption.

  2005cited by this paper
• Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo

  2004cited by this paper
• AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

  2004cited by this paper
• Surprising versatility of Na+-glucose cotransporters: SLC5.

  2004cited by this paper
• Expression of monosaccharide transporters in intestine of diabetic humans.

  2002cited by this paper
• Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect.

  2002cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine.

  2000cited by this paper
• Cholecystokinin Decreases Intestinal Hexose Absorption by a Parallel Reduction in SGLT1 Abundance in the Brush-Border Membrane*

  1998cited by this paper
• The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport.

  1996cited by this paper
• Clinical Pharmacokinetics of Metformin

  1996cited by this paper
• Accumulation of metformin by tissues of the normal and diabetic mouse.

  1994cited by this paper
• Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine.

  1989cited by this paper
• Mechanism of Metformin Action in Non-Insulin-Dependent Diabetes

  1987cited by this paper
• Effect of metformin on glucose metabolism in mouse soleus muscle.

  1986cited by this paper
• Influence of metformin on metabolic effect of insulin in human adipose tissue in vitro.

  1984cited by this paper
• Unique cytochalasin B binding characteristics of the hepatic glucose carrier.

  1983cited by this paper
• Inhibition of intestinal amino acid transport by blood sugar lowering biguanides

  1973cited by this paper
• Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat

  1971cited by this paper
• Specific Inhibition of Gluconeogenesis by Biguanides

  1967cited by this paper

• Effect of Cinnamomum verum L. on intestinal glucose absorption and its use in the treatment of type 2 diabetes

  2025cites this paper
• Impact of Wild Edible Fruits of Arbutus unedo and Crataegus monogyna on Gut Motility, Contraction, Secretion, and Glucose Regulation

  2025cites this paper
• Reframing metformin as a gut-targeted glucose-lowering therapy: Mechanistic insights and translational relevance

  2025cites this paper
• Metformin-mechanisms of its glycemia-reducing effect.

  2025cites this paper
• The Future Revolution of Dadiah and Metformin to Repairing Gut Histopathology by Promoting IgA Expression of Diabetic Rats

  2025cites this paper
• Metformin-regulated glucose flux from the circulation to the intestinal lumen

  2025cites this paper
• Expression of the C-allele of intronic rs8192675 in SLC2A2 is associated with improved glucose response to metformin

  2024cites this paper
• Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology.

  2024cites this paper
• Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes

  2023cites this paper
• Metabolic Complications of Glucocorticoids - Prevention by Metformin.

  2023cites this paper
• Intestinal glucose excretion: A potential mechanism for glycemic control.

  2023cites this paper
• d-allulose reduces postprandial glucose absorption in small intestine by competitive binding to glucose transport sites

  2023cites this paper
• Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review

  2023cites this paper
• Metformin increases the uptake of glucose into the gut from the circulation in high-fat diet-fed male mice, which is enhanced by a reduction in whole-body Slc2a2 expression

  2023cites this paper
• Peanut skin procyanidins reduce intestinal glucose transport protein expression, regulate serum metabolites and ameliorate hyperglycemia in diabetic mice.

  2023cites this paper
• Evaluation of stimbiotic on growth performance and intestinal development of broilers fed corn- or wheat-based diets

  2023cites this paper
• Ion channels and transporters regulate nutrient absorption in health and disease

  2023cites this paper
• Antidiabetic properties of an Ethanolic leaf extract of Launaea taraxacifolia (Willd.) Amin ex C. Jeffrey (Asteraceae) in SD rats

  2022cites this paper
• A Blast From The Past: To Tame Time With Metformin.

  2022cites this paper
• A critical role of AMP‐activated protein kinase in regulating intestinal nutrient absorption, barrier function, and intestinal diseases

  2022influential citation
• The effect of additional acarbose on metformin-associated artificially high 18F-Fluorodeoxyglucose uptake in positron emission tomography/computed tomography

  2022cites this paper
• Regulation of Glucose Insulinotropic Peptide and Intestinal Glucose Transporters in the Diet-Induced Obese Mouse

  2022cites this paper
• The Hormetic Effect of Metformin: “Less Is More”?

  2021cites this paper
• Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis

  2021cites this paper
• Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells

  2021cites this paper
• Mechanisms of Action of Metformin

  2021cites this paper
• Metformin action in the gut―insight provided by [18F]FDG PET imaging

  2021cites this paper
• Dose‐dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by 18F‐labelled fluorodeoxyglucose positron emission tomography‐MRI

  2020cites this paper
• Mulberry 1-deoxynojirimycin (DNJ): an exemplary compound for therapeutics

  2020cites this paper
• Glucose transporters in the small intestine in health and disease

  2020cites this paper
• Effects of Metformin and Sitagliptin Monotherapy on Expression of Intestinal and Renal Sweet Taste Receptors and Glucose Transporters in a Rat Model of Type 2 Diabetes

  2020cites this paper
• Paradoxical activation of AMPK by glucose drives selective EP300 activity in colorectal cancer

  2020cites this paper
• Discontinuation of metformin to prevent metformin-induced high colonic FDG uptake: is 48 h sufficient?

  2020cites this paper
• Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [18F]Fluorodeoxyglucose PET-MRI

  2020cites this paper
• Metformin biodistribution, a key to mechanisms of action?

  2020cites this paper
• Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin

  2020cites this paper
• Antihyperglycemic activity of total extract and fractions of Anogeissus leiocarpus

  2020cites this paper
• Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport

  2019cites this paper
• AMPK-Mediated Regulation of Alpha-Arrestins and Protein Trafficking

  2019cites this paper
• ECEIM consensus statement on equine metabolic syndrome

  2019cites this paper
• Mechanisms of action of metformin with special reference to cardiovascular protection

  2019cites this paper
• Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

  2019cites this paper
• Equines Metabolisches Syndrom – Was gibt es Neues?

  2019cites this paper
• Resveratrol Inhibits Porcine Intestinal Glucose and Alanine Transport: Potential Roles of Na+/K+-ATPase Activity, Protein Kinase A, AMP-Activated Protein Kinase and the Association of Selected Nutrient Transport Proteins with Detergent Resistant Membranes

  2018cites this paper
• Molecular Mechanism of Metformin in DM2- A New Hypothesis

  2018cites this paper
• AMP-Activated Protein Kinase (AMPK)-Dependent Regulation of Renal Transport

  2018cites this paper
• Diabetes-induced testicular oxidative stress, inflammation, and caspase-dependent apoptosis: the protective role of metformin

  2018cites this paper
• Down‐regulation of steroidogenesis‐related genes and its accompanying fertility decline in streptozotocin‐induced diabetic male rats: ameliorative effect of metformin

  2018cites this paper
• Role of AMPK and its possible interactions in metformin therapy and physical exercise - Research perspectives -

  2017cites this paper
• Delphinidin Reduces Glucose Uptake in Mice Jejunal Tissue and Human Intestinal Cells Lines through FFA1/GPR40

  2017cites this paper
• Metformin in gestational diabetes mellitus

  2017cites this paper
• Therapeutics for Equine Endocrine Disorders.

  2017cites this paper
• New insights into the anti-diabetic actions of metformin: from the liver to the gut

  2017cites this paper
• Nephroprotective Effects of Metformin in Diabetic Nephropathy

  2017cites this paper
• Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights.

  2017cites this paper
• The effects of hyperglycemia on glucose metabolism in epithelial ovarian cancer

  2016cites this paper
• Influence of different neuroprotective drugs on dopamine neurotoxicity induced by 3,4-methylenedioxymethamphetamine and MPTP in mice

  2016cites this paper
• The impact of antipsychotic drugs on the expression of genes associated with obesity

  2016cites this paper
• Metformin and the gastrointestinal tract

  2016cites this paper
• Impact of Metformin on Male Reproduction.

  2015cites this paper
• A Framework for the Multilevel Integration of Molecular, Clinical, and Population Data in the Context of Breast Cancer: Challenges and Considerations of Socioecological Conditions and Pharmacogenomics

  2015cites this paper
• Leveraging an Electronic Health Record-Linked Biorepository to Generate a Metformin Pharmacogenomics Hypothesis

  2015cites this paper
• Does apical membrane GLUT2 have a role in intestinal glucose uptake?

  2014cites this paper
• Green tea decoction improves glucose tolerance and reduces weight gain of rats fed normal and high-fat diet.

  2014cites this paper
• Metformin and male reproduction: effects on Sertoli cell metabolism

  2014cites this paper
• A Prospective Analysis of Co-Processed Non-Ionic Surfactants in Enhancing Permeability of a Model Hydrophilic Drug

  2014cites this paper
• Cation-selective Apical Transporters Mediate an Intestinal Cycling Mechanism of Metformin that Enhances its Paracellular Oral Absorption in Mice

  2013cites this paper
• Metformin modulates glucose uptake and transport in Caco-2 cell monolayers

  2013cites this paper
• The intestinal glucose-apelin cycle controls carbohydrate absorption in mice.

  2013cites this paper
• Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose

  2013cites this paper
• Effects of metformin hydrochloride on blood glucose and insulin responses to oral dextrose in horses.

  2013cites this paper
• Metformin in equine metabolic syndrome: an enigma or a dead duck?

  2012cites this paper
• Rosiglitazone and Metformin Have Opposite Effects on Intestinal Absorption of Oligopeptides via the Proton-Dependent PepT1 Transporter

  2012cites this paper
• AMP-activated protein kinase regulation of kidney tubular transport

  2012cites this paper
• Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes.

  2012cites this paper
• A new role for a metabolic star: AMP-activated protein kinase stimulates fat absorption.

  2011cites this paper
• Rosiglitazone and Metformin have opposite effects on intestinal absorption of oligopeptides via the Proton-dependant PepT1 transporter

  2011cites this paper
• Equine metabolic syndrome.

  2010cites this paper